Pharmacoeconomics in Africa: needs, prospect and challenges

被引:2
作者
Ben-Ajepe, Temitope [1 ]
Nwogu, Ifechukwu Benedict [2 ]
Olaoye, Damilola Quazeem [3 ]
Mustapha, Abdulhafeez Ayodele [4 ]
Uwizeyimana, Theogene [5 ]
Adebisi, Yusuff Adebayo [3 ,6 ]
机构
[1] Igbined Univ, Dora Akunyili Coll Pharm, Okada, Edo, Nigeria
[2] Adv Hlth Africa, Lagos, Nigeria
[3] Univ Ibadan, Fac Pharm, Ibadan, Nigeria
[4] Obafemi Awolowo Univ, Fac Pharm, Ife, Nigeria
[5] Mt Kenya Univ Rwanda, Dept Publ Hlth, Kigali, Rwanda
[6] Kateb Univ, Med Res Ctr, Kabul, Afghanistan
关键词
Pharmacoeconomics; Needs; Prospect; Challenges; Africa; ESSENTIAL MEDICINES; SOUTH-AFRICA; STATE; TANZANIA;
D O I
10.1186/s40545-021-00328-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases. Population increases have led to an increase in demands for healthcare, which unfortunately have been met with inequitable distribution of drugs. Hence, the outcomes from healthcare interventions are frequently not maximized. These problems notably call for some economic principles and policies to guide medication selection, procurement, or donation for population prioritization or health insurance. Pharmacoeconomics drives efficient use of scarce or limited resources to maximize healthcare benefits and reduce costs. It also brings to play tools that rate therapy choice based on the quality of life added to the patient after a choice of intervention was made over an alternative. In this paper, we commented on the needs, prospect, and challenges of pharmacoeconomics in Africa.
引用
收藏
页数:4
相关论文
共 25 条
[1]  
Adebisi Y A., 2019, International Journal of Infection, V6, P105, DOI DOI 10.5812/IJI.92250
[2]  
Adebisi Y A., 2020, Int J Health Life Sci, V6, DOI DOI 10.5812/IJHLS.102552
[3]   The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study [J].
Akande-Sholabi, Wuraola ;
Adebisi, Yusuff Adebayo .
PAN AFRICAN MEDICAL JOURNAL, 2020, 35 :1-2
[4]  
[Anonymous], 2004, WHO publication Equitable Access to Essential Medicines: A Framework for Collective Action
[5]   Is There a Role for Pharmacoeconomics in Developing Countries? [J].
Babar, Zaheer-Ud-Din ;
Scahill, Shane .
PHARMACOECONOMICS, 2010, 28 (12) :1069-1074
[6]   Drug and therapeutics committees in Nigeria: evaluation of scope and functionality [J].
Fadare, Joseph O. ;
Ogunleye, Olayinka ;
Obiako, Reginald ;
Orubu, Samuel ;
Enwere, Okezie ;
Ajemigbitse, Adetutu A. ;
Meyer, Johanna C. ;
Enato, Ehijie ;
Massele, Amos ;
Godman, Brian ;
Gustafsson, Lars L. .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (12) :1255-1262
[7]   The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: A review [J].
Gavaza, Paul ;
Rascati, Karen ;
Brown, Carolyn ;
Lawson, Kenneth ;
Mann, Teresa .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2008, 69 (03) :268-285
[8]   The State of Health Economic Research in South Africa A Systematic Review [J].
Gavaza, Paul ;
Rascati, Karen L. ;
Oladapo, Abiola O. ;
Khoza, Star .
PHARMACOECONOMICS, 2012, 30 (10) :925-940
[9]   The State of Health Economic Evaluation Research in Nigeria A Systematic Review [J].
Gavaza, Paul ;
Rascati, Karen L. ;
Oladapo, Abiola O. ;
Khoza, Star .
PHARMACOECONOMICS, 2010, 28 (07) :539-553
[10]   The cost-effectiveness of treating childhood cancer in 4 centers across sub-Saharan Africa [J].
Githang'a, Jessie ;
Brown, Biobele ;
Chitsike, Inam ;
Schroeder, Kristin ;
Chekwenda-Makore, Nester ;
Majahasi, Flora ;
Ogundoyin, Olakayode ;
Renner, Lorna ;
Petricca, Kadia ;
Denburg, Avram E. ;
Horton, Sue E. ;
Gupta, Sumit .
CANCER, 2021, 127 (05) :787-793